Mustafa A-Jabbar Al-Jumaili
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Synthesis and Characterization of Novel Bis-Schiff Bases Based O-Tolidine Mustafa A-Jabbar Al-Jumaili
OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan Vol. 2 No. 6 (2024): November : OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/obat.v2i6.828

Abstract

Three novel Schiff base (A-C) was reported in this study by reaction of o-tolidine with three different aldehydes 2-bromobenzaldehyde, 3-hydroxybenzaldehyde, and 2,4-dihydroxybenzaldehyde to attain three novel Bis-Schiff Bases ligands in high yield (86-97%). Thin-layer chromatography (TLC) technique is used to monitor the reaction. These agents were characterized by 13C, 1H NMR, HRMS, FTIR, and melting point. The synthesized tcompounds (A-C) are expected to have considerable biological activity owing to their molecular structure, which incorporates essential imine functional groups.
Dehydroepiandrosterone Sulfate Deficiencies as Independent Predictors of Increased Coronary Artery Disease in Men with Type II Diabetes Mellitus Mustafa A-Jabbar Al-Jumaili; Abdullah Ali Mohammed; Hawraa M. Alaa Alden; Sura A. Abdulsattar
OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan Vol. 3 No. 1 (2025): January: OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/obat.v3i1.984

Abstract

The adrenal cortex synthesis the steroid hormone dehydroepiandrosterone (DHEA), has a significant effect on diabetes mellitus. Our study targeted to estimate the relationship between serum levels of DHEA sulphate (DHEAS) and the risk of CAD complication for T2DM in men. Ninety Iraqi male subjects were divided into three groups. Each group has thirty people: thirty people type 2 with diabetes mellitus, thirty person type 2 diabetes mellitus patients with CAD complications, and the control group has thirty healthy people. A significant decrease (p<0.01) of DHEAS, was observed in T2DM with CAD (120.8 µg/dl) compared to both T2DM (141.26 µg/dl) and the control group (239.86 µg/dl). Meanwhile, an increased coronary risk index in T2DM with CAD (10.68) compared to both T2DM (7.56) and control group (4.41) was observed. These findings were confirmed by the negative correlation of DHEAs with coronary risk index. We suggested that a decreased level of DHEAS value may be a beneficial sign for future CAD in patients with T2DM.